Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Un-Audited Standalone Financial Results For The Half Year Ended September 30 2026
07-Nov-2026 | Source : BSEWith reference to the subject matter and pursuant to the Regulation 30 32 & 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ("SEBI LODR") we would like to inform you that the Board of Directors of the Company at its meeting held today i.e Saturday 07th November 2026 at corporate office of the company at 5TH Floor 501 SAKAR 4 Opp. Town Hall Ashram Road Ahmedabad Gujarat -380006 has considered and approved the following:
Submission Of The Un-Audited Standalone Financial Results For The Half Year Ended September 30 2026
07-Nov-2026 | Source : BSEAttached herewith Financial Results for Half year ended 30th September 2026
Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
07-Nov-2026 | Source : BSEAttached herewith Statement of Deviation for quarter ended 30th September 2026
Corporate Actions
No Upcoming Board Meetings
Shelter Pharma Ltd has declared 3% dividend, ex-date: 23 Sep 25
No Splits history available
No Bonus history available
No Rights history available